Clinical Trial

Effects of Intradialytic Exercise on Muscle Oxygenation and Dialysis Adequacy

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated September 3, 2025 (before its estimated November 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled trial will evaluate the effects of a 12-week intradialytic combined exercise program, consisting of aerobic and resistance training, in patients with stage 5 chronic kidney disease receiving maintenance hemodialysis. Sarcopenia, a progressive loss of muscle mass and strength, is common in this population due to chronic disease burden and the sedentary nature of dialysis sessions. The intervention group will perform structured exercise three times per week during the first two hours of dialysis, while the control group will continue routine dialysis care without exercise. The primary aim is to investigate whether intradialytic exercise can improve dialysis adequacy and muscle oxygenation, and reduce sarcopenia severity. Secondary objectives include evaluating changes in physical performance, muscle strength, fatigue levels, and health-related quality of life. Approximately 40 participants will be randomized into intervention and control groups. Outcomes will be assessed through clinical measurements, functional tests, and patient-reported questionnaires before and after the intervention period.
Trial Details
NCT Number NCT07151742
Lead Sponsor Istinye University
Conditions Chronic Kidney Disease, Stage 5, Sarcopenia
Enrollment 40 participants
Start Date 2025-05-25
Primary Completion 2025-11-25 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-03